PROVIDER PROFILE · NPI 1487650677
Toni CanigliaN.P.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,008
Unique beneficiaries
—
Total services
3,622
Distinct HCPCS
13
Medicare payment
$52K
PRESCRIBING · PART D · 2024
Total Rx claims
1,601
Beneficiaries
—
Total drug cost
$265K
Distinct drugs
18
Brand share
43.5%
Top prescribed drugs
Azelastine Hcl279 claims
Fluticasone Propionate257 claims
Albuterol Sulfate201 claims
Fluticasone/Umeclidin/Vilanter139 claims
Montelukast Sodium111 claims
QUALITY · MIPS · 2024
Final MIPS score
93.2
Quality
88.6
Cost
75.4
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
0.77%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$739
Payment records
20
By payment type
Food and Beverage$613
Education$99
Travel and Lodging$27
Top paying entities
Food and Beverage$613
Education$99
Travel and Lodging$27
REFERRAL NETWORK
Where Toni Caniglia's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Howard Pettigrew Allergy/ Immunology · Fresno, CA | 12 | 34 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE